Search research articles
Contact Us
Filters
Showing results (911-920 of 920) with videos related to
Page
of 92
Sort By:
You have reached the last page of results.
This site can display upto 920 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
George D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Science Translational Medicine
|
August 15, 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J Roberts, Linping Zhang, Filip Janku, et al.
Cancer
|
September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
JAMA Oncology
|
May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
Anna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Journal of Chemical Information and Modeling
|
November 5, 2024
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein
Fengling Li, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Annals of Emergency Medicine
|
August 18, 2023
The Management of Children and Youth With Pediatric Mental and Behavioral Health Emergencies
Mohsen Saidinejad, Susan Duffy, Dina Wallin, et al.
Page
of 92
Search research articles
Search
Showing results (911-920 of 920) with videos related to
Sort By:
Page
of 92
You have reached the last page of results.
This site can display upto 920 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
George D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Science Translational Medicine
|
August 15, 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J Roberts, Linping Zhang, Filip Janku, et al.
Cancer
|
September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
JAMA Oncology
|
May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
Anna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Journal of Chemical Information and Modeling
|
November 5, 2024
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein
Fengling Li, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Annals of Emergency Medicine
|
August 18, 2023
The Management of Children and Youth With Pediatric Mental and Behavioral Health Emergencies
Mohsen Saidinejad, Susan Duffy, Dina Wallin, et al.
Page
of 92